Sequent Scientific (India) Performance
| SEQUENT Stock | 203.32 4.05 2.03% |
On a scale of 0 to 100, Sequent Scientific holds a performance score of 8. The entity has a beta of -0.0079, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sequent Scientific are expected to decrease at a much lower rate. During the bear market, Sequent Scientific is likely to outperform the market. Please check Sequent Scientific's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Sequent Scientific's existing price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sequent Scientific Limited are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting technical and fundamental indicators, Sequent Scientific unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 10:2 | Ex Dividend Date 2021-09-08 | Last Split Date 2016-02-25 |
1 | Sequent Scientific shares rise 15, hit 52-week high heres why - Business Today | 09/26/2024 |
2 | Sequent Scientifics Stock Sees 5 percent Increase, Outperforms Sector and Sensex - MarketsMojo | 11/06/2024 |
| Begin Period Cash Flow | 415.7 M |
Sequent |
Sequent Scientific Relative Risk vs. Return Landscape
If you would invest 16,162 in Sequent Scientific Limited on September 2, 2024 and sell it today you would earn a total of 4,170 from holding Sequent Scientific Limited or generate 25.8% return on investment over 90 days. Sequent Scientific Limited is generating 0.4263% of daily returns and assumes 3.7372% volatility on return distribution over the 90 days horizon. Simply put, 33% of stocks are less volatile than Sequent, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sequent Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sequent Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sequent Scientific Limited, and traders can use it to determine the average amount a Sequent Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1141
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SEQUENT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.74 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Sequent Scientific is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sequent Scientific by adding it to a well-diversified portfolio.
Sequent Scientific Fundamentals Growth
Sequent Stock prices reflect investors' perceptions of the future prospects and financial health of Sequent Scientific, and Sequent Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sequent Stock performance.
| Return On Equity | -0.0405 | ||||
| Return On Asset | 0.0031 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 53.69 B | ||||
| Shares Outstanding | 249.35 M | ||||
| Price To Book | 7.33 X | ||||
| Price To Sales | 3.56 X | ||||
| Revenue | 13.7 B | ||||
| Gross Profit | 5.63 B | ||||
| EBITDA | 549.8 M | ||||
| Net Income | (358.69 M) | ||||
| Total Debt | 4.88 B | ||||
| Book Value Per Share | 26.37 X | ||||
| Cash Flow From Operations | 305.95 M | ||||
| Earnings Per Share | 0.66 X | ||||
| Total Asset | 15.4 B | ||||
| Retained Earnings | 1.2 B | ||||
About Sequent Scientific Performance
Assessing Sequent Scientific's fundamental ratios provides investors with valuable insights into Sequent Scientific's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Sequent Scientific is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Sequent Scientific is entity of India. It is traded as Stock on NSE exchange.Things to note about Sequent Scientific performance evaluation
Checking the ongoing alerts about Sequent Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sequent Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sequent Scientific had very high historical volatility over the last 90 days | |
| The company reported the revenue of 13.7 B. Net Loss for the year was (358.69 M) with profit before overhead, payroll, taxes, and interest of 5.63 B. | |
| About 53.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Sequent Scientifics Stock Sees 5 percent Increase, Outperforms Sector and Sensex - MarketsMojo |
- Analyzing Sequent Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sequent Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Sequent Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sequent Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sequent Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sequent Scientific's stock. These opinions can provide insight into Sequent Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Sequent Stock Analysis
When running Sequent Scientific's price analysis, check to measure Sequent Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sequent Scientific is operating at the current time. Most of Sequent Scientific's value examination focuses on studying past and present price action to predict the probability of Sequent Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sequent Scientific's price. Additionally, you may evaluate how the addition of Sequent Scientific to your portfolios can decrease your overall portfolio volatility.